Data / Form D filings / EdenRoc Sciences LLC
EdenRoc Sciences LLC: Form D filings
EdenRoc Sciences LLC, a biotechnology company in Worcester, MA, filed 13 Form D notices with the SEC between 2016 and 2024. The latest, on November 15, 2024, reports $2.8 million sold of a $50 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 Barber Avenue, Worcester, MA, 01606
- Phone
- (612) 600-0213
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1685567
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | New notice | $50,000,000 | $2,750,000 | $47,250,000 | 3 | Nov 7, 2024 | sec.gov |
| Jul 16, 2024 | Amendment | $64,175,000 | $64,175,000 | 50 | Jun 17, 2022 | sec.gov | |
| Dec 26, 2023 | New notice | Indefinite | $55,525,000 | 41 | Jun 17, 2022 | sec.gov | |
| May 24, 2022 | Amendment | $35,900,016 | $35,900,016 | 22 | May 5, 2021 | sec.gov | |
| Jan 19, 2022 | Amendment | $27,600,016 | $27,600,016 | 19 | May 5, 2021 | sec.gov | |
| Nov 3, 2021 | New notice | Indefinite | $19,100,016 | 15 | May 5, 2021 | sec.gov | |
| Nov 3, 2021 | New notice | $18,000,000 | $18,000,000 | 10 | Aug 13, 2020 | sec.gov | |
| Jul 31, 2020 | New notice | Indefinite | $17,600,000 | 11 | Jan 13, 2020 | sec.gov | |
| Jul 30, 2019 | New notice | $47,500,000 | $8,000,000 | $39,500,000 | 4 | Jul 15, 2019 | sec.gov |
| Feb 20, 2019 | New notice | $13,500,000 | $13,500,000 | 4 | Feb 5, 2019 | sec.gov | |
| Mar 19, 2018 | New notice | $15,000,000 | $15,000,000 | 2 | Mar 5, 2018 | sec.gov | |
| Jul 26, 2017 | New notice | $15,000,000 | $15,000,000 | 3 | Jul 12, 2017 | sec.gov | |
| Sep 29, 2016 | New notice | $30,000,000 | $30,000,000 | 1 | Sep 13, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edward Schulak | Executive Officer, Director | |
| Todd Dickinson | Director | |
| Christopher Wibbleman | Director | |
| J. Taylor Crandall | Director | |
| Christopher McDoniel | Executive Officer | |
| Mathew Easterday | Executive Officer | |
| David Sinclair | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Nov 11, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EdenRoc Sciences LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.